Biotechnology has led the most recent decline on the market as witnessed by the performance of iShares Nasdaq Biotechnology Index (NASDAQ:IBB). However, one medical product name that has outperformed this ETF has been a small company called Atrion Corporation (NASDAQ:ATRI). Over the past decade, the company has seen its share price rise over 500% from $45 in 2004 to over $300 in 2014. Both of these trends can be seen in the two price charts found below.
Atrion Corporation develops and manufactures products primarily used for medical applications. The company's expertise revolves primarily around three fields found in fluid delivery devices, cardiovascular products, and ophthalmic products. For 2013, these three fields accounted for 39%,...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|